Table 1.
Number of Positive Patients and Baseline Clinical Characteristics of the Patients Included in the Studies Investigating the Prevalence of Coronary Microvascular Disease
| Study | Patients included | No. positive, n (%) | Age, y | Women, n (%) | Hypertension, n (%) | Diabetes, n (%) | Dyslipidemia, n (%) | Current smoker, n (%) |
|---|---|---|---|---|---|---|---|---|
| Cassar, 2009 13 | 376 | 170 (45%) | 49±11 | 254 (68%) | 157 (42%) | 36 (10%) | 208 (55%) | NA |
| Godo, 2020 32 | 148 | 91 (62%) | 44±9 | 111 (75%) | 79 (53%) | 11 (7%) | 91 (62%) | 60 (41%) |
| Ford, 2018 33 | 151 | 78 (52%) | 61±10 | 111 (74%) | 125 (81%) | 29 (19.2%) | 120 (79.5%) | 24 (15.9%) |
| Graf, 2006 35 | 58 | 42 (72%) | 58±10 | 39 (67%) | NA | 8 (18%) | NA | 17 (29%) |
| Hasdai, 1998 36 | 203 | 118 (58%) | 51 (17–78) | 158 (78%) | 59 (29%) | 8 (4%) | 88 (43.3%) | 28 (27%) |
| Kobayashi, 2015 39 | 157 | 39 (25%) | 64±12 | 117 (29%) | 77 (49%) | 38 (24%) | 91 (58%) | 47 (30%) |
| Kotecha, 2019 40 | 23 | 16 (70%) | 63±8 | NA | 6 (26%) | NA | NA | NA |
| Lee, 2015 42 | 137 | 38 (28%) | 54±11 | 107 (77%) | 74 (53%) | 32 (23%) | 87 (63%) | 11 (8%) |
| Michelsen, 2018 43 | 919 | 241 (26%) | 62±9 | 919 (100%) | 467 (51%) | 117 (13%) | 580 (63%) | 149 (16%) |
| Murthy, 2014 44 | 1218 | 641 (53%) | 62 (53–69) | 813 (67%) | 894 (73%) | 363 (30%) | 663 (54%) | 121 (10%) |
| Pargaonkar, 2019 47 | 155 | 34 (22%) | 54±13 | 119 (77%) | 68 (44%) | 26 (17%) | 90 (58%) | 23 (15%) |
| Pargaonkar, 2020 48 | 88 | 32 (36%) | NA | 53 (60%%) | NA | NA | NA | NA |
| Pepine, 2010 49 | 152 | 74 (49%) | 55±10 | 189 (100%) | 57 (30%) | 21 (11%) | 50 (26%) | 19 (10%) |
| Quesada, 2020 50 | 150 | 67 (45%) | 54±12 | 36 (24%) | 75 (50%) | 25 (17%) | 90 (60%) | 22 (15%) |
| Sade, 2009 53 | 65 | 27 (40%) | 55±8 | 68 (100%) | 37 (54%) | NA | 35 (52%) | 16 (24%) |
| Safdar, 2020 54 | 124 | 81 (65%) | 51±11 | 91 (73%) | 81 (65%) | 42 (34%) | 53 (43%) | 20 (16%) |
| Sakamoto, 2012 55 | 73 | 12 (16%) | 65±8 | 36 (49%) | 33 (45%) | 6 (8%) | 17 (23%) | 11 (15%) |
| Sara, 2016 56 | 926 | 281 (30%) | 52±13 | 567 (61%) | 371 (40%) | 59 (6%) | 485 (52%) | 111 (12%) |
| Schindler, 2005 58 | 72 | 50 (69%) | 58 _ 8 | 28 (39%) | 50 (69%) | 3 (4%) | 30 (42%) | 18 (25%) |
| Sicari, 2009 61 | 394 | 87 (22%) | 61±10 | 223 (57%) | 238 (60%) | 69 (18%) | NA | 120 (31%) |
| Suda, 2019 63 | 187 | 75 (40%) | 63±12 | 74 (40%) | 100 (54%) | 52 (28%) | 66 (35%) | 52 (28%) |
| Taqueti, 2018 64 | 201 | 108 (54%) | 66 (57–79) | 130 (65%) | 152 (76%) | 129 (64%) | 66 (33%) | 16 (8%) |
| Uemura, 2016 65 | 61 | 16 (26%) | 59±15 | 18 (30%) | 37 (61%) | 15 (25%) | NA | 37 (61%) |
| Verna, 2018 66 | 101 | 45 (45%) | 60±11 | 48 (48%) | 58 (57%) | 9 (9%) | 53 (53%) | 21 (21%) |
| Solberg, 2019 62 | 66 | 11 (17%) | 54±9 | 66 (100%) | 15 (23%) | 2 (3%) | 8 (12%) | 44 (67%) |
| Schroder, 2019 59 | 174 | 49 (28%) | 64±10 | NA | NA | NA | NA | NA |
| Sara, 2019 57 | 129 | 49 (38%) | 50±12 | 61 (47%) | NA | NA | NA | NA |
| Kumar, 2020 41 | 163 | 107 (66%) | 57±12 | 79 (48%) | 118 (72%) | 37 (23%) | 122 (75%) | 30 (18%) |
| De Vita, 2019 34 | 30 | 18 (60%) | 67±10 | 19 (63%) | 19 (63%) | 4 (13%) | 16 (53%) | 15 (50%1) |
| Mygind, 2016 45 | 54 | 20 (37%) | 62±8 | 54 (100%) | 29 (54%) | NA | 34 (63%) | 34 (63%) |
| Panza, 1997 46 | 66 | 13 (20%) | 49±10 | 44 (67%) | NA | Na | NA | NA |
| Schroder, 2018 60 | 97 | 37 (38%) | 62 (31–79) | 97 (100%) | NA | NA | NA | NA |
| Reis, 1999 52 | 48 | 29 (60%) | 54±10 | 48 (100%) | 23 (48%) | 6 (13%) | 24 (49%) | NA |
| Kim, 2013 38 | 40 | 11 (28%) | 53±11 | NA | NA | NA | NA | NA |
| Ishimori, 2011 37 | 18 | 8 (44%) | 41±11 | 18 | NA | NA | NA | NA |
| Rahman, 2019 51 | 85 | 45 (53%) | 57±10 | 66 (78%) | 25 (29%) | 11 (13%) | 23 (27%) | 12 (14%) |
| Konst, 2020 67 | 103 | 38 (37%) | 62±9 | NA | NA | NA | NA | NA |
NA indicates information is not available.